Physician profile
Gregory Diorio
NPI 1427369867
$2,130.06
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $289 · 2021: $35.79 · 2022: $13.23 · 2023: $568 · 2024: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $330.59 | 2019-2023 | Xtandi |
| Dendreon Pharmaceuticals LLC | $230.88 | 2019-2020 | |
| Boston Scientific Corporation | $218.63 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $157.79 | 2019-2024 | Adstiladrin |
| Teleflex LLC | $148.33 | 2023 | Urolift |
| Davol INC. | $145.45 | 2023 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $137.40 | 2019-2024 | |
| Medtronic, INC. | $123.20 | 2023 | Interstim |
| Myriad Genetic Laboratories, INC. | $121.88 | 2024 | Prolaris |
| Coloplast Corp | $113.53 | 2019-2024 | |
| Medtronic USA, INC. | $111.07 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $92.26 | 2019 | |
| Endo Pharmaceuticals INC. | $27.74 | 2020 | |
| Pfizer INC. | $26.03 | 2019 | |
| Blue Earth Diagnostics | $25.13 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.84 | 2023 | Botox |
| Allergan, INC. | $19.91 | 2021 | |
| Neotract INC. | $16.00 | 2019 | |
| 180 Medical, INC. | $15.88 | 2021 | |
| Merck Sharp & Dohme LLC | $15.37 | 2020 | |
| Fortovia Therapeutics, INC. | $14.92 | 2020 | |
| Rochester Medical Corporation | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Diorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.